Does Insurance Still Cover Vascepa?
Vascepa (icosapent ethyl) remains covered by most commercial insurance plans, Medicare Part D, and Medicaid in the US, though coverage varies by plan, prior authorization requirements, and pharmacy benefits manager (PBM). As of 2024, about 90% of patients with commercial coverage have access with $0-$10 copays after prior auth, per manufacturer data from Amarin.[1] Generic versions aren't available yet due to ongoing patent protection until at least 2031, so coverage tracks the brand drug.[2]
Why Might Coverage Get Denied?
Denials often stem from step therapy (requiring trials of fish oil or statins first) or failure to meet FDA criteria for cardiovascular risk reduction (e.g., triglycerides 150+ mg/dL on statins). PBMs like Express Scripts and CVS Caremark frequently require documentation of these. Appeal success rates exceed 80% with physician support.[1][3]
How Coverage Changed After Generic Challenges
Patent litigation delayed generics; a key Vascepa patent expires in 2030, with pediatric exclusivity pushing to 2031. This keeps it as the sole option, maintaining broad coverage similar to pre-2020 REDUCE-IT trial levels. No generics launched as of October 2024.[2][4]
Medicare vs. Commercial Coverage Details
- Medicare Part D: Covered on 95%+ of plans; average copay $50-100 post-deductible. Listed on all major formularies (e.g., AARP, Wellcare).[5]
- Commercial: Tier 2-3 on most plans (e.g., UnitedHealthcare, Blue Cross); prior auth needed for 70% of claims. Employer plans often fully cover for indicated uses.[1][3]
Check your plan's formulary via the insurer's portal or tools like GoodRx.
Patient Assistance if Not Covered
Amarin's VASCEPA360 program offers copay cards reducing out-of-pocket to $0 for eligible commercially insured patients (up to $18,000/year savings). Uninsured/low-income qualify for free drug via patient assistance foundation. Apply at vascepa.com/support.[1]
Cost Without Insurance
Retail price is $350-450 for 120 capsules (1-month supply). Discounts via GoodRx drop it to $250-300.[6]
Sources
[1]: Amarin VASCEPA Access Report
[2]: DrugPatentWatch.com - Vascepa Patents
[3]: CoverMyMeds Prior Auth Data
[4]: FDA Orange Book - Vascepa Exclusivity
[5]: Medicare Plan Finder
[6]: GoodRx - Vascepa Pricing